Background:
Novel Corona virus is a type of enveloped viruses with a single stranded RNA enclosing helical
nucleocapsid. The envelope consists of spikes on the surface which are made up of proteins through which virus enters into
human cells. Until now there is no specific drug or vaccine available to treat COVID-19 infection. In this scenario, reposting
of drug or active molecules may provide rapid solution to fight against this deadly disease.
Objective:
We had selected 30 phytoconstituents from the different plants which are reported for antiviral activities against
corona virus (CoVs) and performed insilico screening to find out phytoconstituents which have potency to inhibit specific
target of novel corona virus.
Methods:
We had perform molecular docking studies on three different proteins of novel corona virus namely COVID-19
main protease (3CL pro), papain-like protease (PL pro) and spike protein (S) attached to ACE2 binding domain. The screening of the phytoconstituents on the basis of binding affinity compared to standard drugs. The validations of screened compounds were done using ADMET and bioactivity prediction.
Results:
We had screened five compounds biscoclaurine, norreticuline, amentoflavone, licoricidin and myricetin using insilico approach. All compounds found safe in insilico toxicity studies. Bioactivity prediction reviles that these all compounds
may act through protease or enzyme inhibition. Results of compound biscoclaurine norreticuline were more interesting as
this biscoclaurine had higher binding affinity for the target 3CLpro and PLpro targets and norreticuline had higher binding
affinity for the target PLpro and Spike protein.
Conclusion:
Our study concludes that these compounds could be further explored rapidly as it may have potential to fight
against COVID-19.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.